Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

Autor:	Heidi Ko, Rebecca A. Previs, Kyle C. Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A. Severson, Shakti Ramkissoon, Kamal S. Saini
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	HER2-low Metastatic breast cancer HER2 testing HER2-directed antibody–drug conjugate Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Oncology and Therapy, Vol 12, Iss 1, Pp 13-17 (2023)
Druh dokumentu:	article
ISSN:	2366-1070 2366-1089 10453946
DOI:	10.1007/s40487-023-00249-0
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/13b6eb10453946f2ba69ec31662e4323 Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ